ATE89602T1 - Verfahren zur herstellung von menschlichem epidermalwachstumsfaktor und dessen analogen. - Google Patents
Verfahren zur herstellung von menschlichem epidermalwachstumsfaktor und dessen analogen.Info
- Publication number
- ATE89602T1 ATE89602T1 AT87301490T AT87301490T ATE89602T1 AT E89602 T1 ATE89602 T1 AT E89602T1 AT 87301490 T AT87301490 T AT 87301490T AT 87301490 T AT87301490 T AT 87301490T AT E89602 T1 ATE89602 T1 AT E89602T1
- Authority
- AT
- Austria
- Prior art keywords
- growth factor
- epidermal growth
- analogues
- human epidermal
- glu
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 101500025419 Homo sapiens Epidermal growth factor Proteins 0.000 title 1
- 229940116978 human epidermal growth factor Drugs 0.000 title 1
- GVUGOAYIVIDWIO-UFWWTJHBSA-N nepidermin Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C1=CC=C(O)C=C1 GVUGOAYIVIDWIO-UFWWTJHBSA-N 0.000 title 1
- 108020001507 fusion proteins Proteins 0.000 abstract 2
- 102000037865 fusion proteins Human genes 0.000 abstract 2
- 102000009024 Epidermal Growth Factor Human genes 0.000 abstract 1
- 108091005804 Peptidases Proteins 0.000 abstract 1
- 239000004365 Protease Substances 0.000 abstract 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 abstract 1
- 101000829189 Staphylococcus aureus Glutamyl endopeptidase Proteins 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
- C12N15/71—Expression systems using regulatory sequences derived from the trp-operon
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/485—Epidermal growth factor [EGF], i.e. urogastrone
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
- C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/50—Fusion polypeptide containing protease site
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/848—Escherichia
- Y10S435/849—Escherichia coli
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/12—Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/30—Signal or leader sequence
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/832,337 US4743679A (en) | 1986-02-24 | 1986-02-24 | Process for producing human epidermal growth factor and analogs thereof |
| EP87301490A EP0234888B1 (de) | 1986-02-24 | 1987-02-20 | Verfahren zur Herstellung von menschlichem Epidermalwachstumsfaktor und dessen Analogen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE89602T1 true ATE89602T1 (de) | 1993-06-15 |
Family
ID=25261365
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT87301490T ATE89602T1 (de) | 1986-02-24 | 1987-02-20 | Verfahren zur herstellung von menschlichem epidermalwachstumsfaktor und dessen analogen. |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US4743679A (de) |
| EP (1) | EP0234888B1 (de) |
| JP (1) | JPS62246600A (de) |
| AT (1) | ATE89602T1 (de) |
| AU (1) | AU595290B2 (de) |
| CA (1) | CA1269055A (de) |
| DE (1) | DE3785864T2 (de) |
Families Citing this family (66)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5087564A (en) * | 1985-06-20 | 1992-02-11 | Monsanto Company | Release of recombinant peptides from polypeptides using V8 endopeptidase |
| US5618715A (en) * | 1985-12-20 | 1997-04-08 | Oncogen Limited Partnership | Oncostatin M and novel compositions having anti-neoplastic activity |
| US4929442A (en) * | 1986-09-26 | 1990-05-29 | Exovir, Inc. | Compositions suitable for human topical application including a growth factor and/or related materials |
| DK175535B1 (da) * | 1987-03-04 | 2004-11-29 | Daiichi Suntory Pharma Co Ltd | Fremgangsmåde til fremstilling af et fysiologisk aktivt cysteinholdigt peptid |
| US5416007A (en) * | 1987-03-20 | 1995-05-16 | Creative Biomolecules, Inc. | Enhanced proteolytic cleavage of recombinant fusion proteins |
| US5013653A (en) * | 1987-03-20 | 1991-05-07 | Creative Biomolecules, Inc. | Product and process for introduction of a hinge region into a fusion protein to facilitate cleavage |
| US5215896A (en) * | 1987-03-20 | 1993-06-01 | Creative Biomolecules, Inc. | Leader sequences for the production of recombinant proteins |
| US5681713A (en) * | 1987-05-08 | 1997-10-28 | Smithkline Beecham Corporation | Expression of heterologous proteins in Drosophila cells |
| WO1989001489A1 (en) * | 1987-08-10 | 1989-02-23 | Commonwealth Scientific And Industrial Research Or | Control of angiogenesis and compositions and methods therefor |
| US5366081A (en) | 1987-08-26 | 1994-11-22 | United States Surgical Corporation | Packaged synthetic absorbable surgical elements |
| US5472702A (en) * | 1987-08-26 | 1995-12-05 | United States Surgical Corporation | Sterilization of growth factors |
| US5226912A (en) | 1987-08-26 | 1993-07-13 | United States Surgical Corporation | Combined surgical needle-braided suture device |
| US5222978A (en) | 1987-08-26 | 1993-06-29 | United States Surgical Corporation | Packaged synthetic absorbable surgical elements |
| US5306289A (en) * | 1987-08-26 | 1994-04-26 | United States Surgical Corporation | Braided suture of improved characteristics |
| GB2210618B (en) * | 1987-10-08 | 1991-10-16 | British Bio Technology | Synthetic egf gene |
| US5270176A (en) * | 1987-11-20 | 1993-12-14 | Hoechst Aktiengesellschaft | Method for the selective cleavage of fusion proteins with lysostaphin |
| WO1989006694A1 (en) * | 1988-01-15 | 1989-07-27 | Trustees Of The University Of Pennsylvania | Process for selection of proteinaceous substances which mimic growth-inducing molecules |
| FI891308A7 (fi) * | 1988-03-24 | 1989-09-25 | Oncogen | Uudet polypeptidit, joilla on kasvutekijäaktiivisuutta sekä polypeptideitä koodittavat nukleiinihapposekvenssit |
| US5208144A (en) * | 1988-08-23 | 1993-05-04 | The General Hospital Corporation | Method for detection of human dna containing the gene encoding low density lipoprotein receptor |
| EP0358977A1 (de) * | 1988-08-23 | 1990-03-21 | The General Hospital Corporation | Kloniertes Nephritis-Antigen |
| US5102789A (en) * | 1989-03-15 | 1992-04-07 | The Salk Institute Biotechnology/Industrial Associates, Inc. | Production of epideramal growth factor in pichia pastoris yeast cells |
| US5047335A (en) * | 1988-12-21 | 1991-09-10 | The Regents Of The University Of Calif. | Process for controlling intracellular glycosylation of proteins |
| US7026291B1 (en) | 1989-01-31 | 2006-04-11 | The United States Of America As Represented By The Department Of Health And Human Services | Epithelial cell specific growth factor, keratinocyte growth factor (KGF) |
| DK0555205T3 (da) | 1989-01-31 | 2001-03-05 | Jeffrey S Rubin | DNA, der koder for en væstfaktor, som er specifik for epitelceller |
| IL93173A0 (en) * | 1989-02-01 | 1990-11-05 | Shionogi & Co | Production of glucagon |
| US5158935A (en) * | 1989-05-12 | 1992-10-27 | Chiron Corporation | Human epidermal growth factor having substitution at position 11 |
| US5070188A (en) * | 1989-07-24 | 1991-12-03 | Ethicon, Inc. | Acylated epidermal growth factor |
| US5359831A (en) | 1989-08-01 | 1994-11-01 | United States Surgical Corporation | Molded suture retainer |
| US5246104A (en) * | 1989-08-01 | 1993-09-21 | United States Surgical Corporation | Molded suture retainer |
| US5599906A (en) * | 1990-04-13 | 1997-02-04 | Schering Corporation | Protease assays |
| US5219998A (en) * | 1990-06-04 | 1993-06-15 | Levin Robert H | Yeast-derived epidermal growth factor |
| US7294712B2 (en) | 1990-06-04 | 2007-11-13 | Aventis Pharma S.A. | Nucleotide sequences coding for variable regions of β chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic uses |
| US5434135A (en) * | 1990-08-02 | 1995-07-18 | Indu Parikh | Growth factor compositions, preparation and use |
| US5202239A (en) * | 1990-08-07 | 1993-04-13 | Scios Nova Inc. | Expression of recombinant polypeptides with improved purification |
| CA2059245C (en) * | 1991-02-08 | 2004-07-06 | Michael P. Chesterfield | Method and apparatus for calendering and coating/filling sutures |
| WO1992013950A2 (fr) * | 1991-02-12 | 1992-08-20 | Roussel-Uclaf | SEQUENCES NUCLEOTIDIQUES CODANT POUR DES REGIONS VARIABLES DE CHAINES β DES RECEPTEURS DES LYMPHOCYTES T HUMAINS, SEGMENTS PEPTIDIQUES CORRESPONDANTS ET LES APPLICATIONS DIAGNOSTIQUES ET THERAPEUTIQUES |
| AU2489992A (en) | 1991-08-16 | 1993-03-16 | Chiron Corporation | Muteins of epidermal growth factor exhibiting enhanced binding at low ph |
| JP3419454B2 (ja) * | 1991-11-06 | 2003-06-23 | ガーヴァン インスティチュート オブ メディカル リサーチ | ヒト神経ペプチドｙ−ｙ１レセプター |
| US5861301A (en) * | 1992-02-20 | 1999-01-19 | American Cayanamid Company | Recombinant kinase insert domain containing receptor and gene encoding same |
| JPH08501203A (ja) * | 1992-06-03 | 1996-02-13 | ケイス・ウエスタン・リザーブ・ユニバーシティー | 生理活性物質を連続的に適用するための包帯 |
| US5656456A (en) * | 1992-07-13 | 1997-08-12 | Bionebraska, Inc. | Chemical method for selective modification of the N- and/or C-terminal amino acid α-carbon reactive group of a recombinant polypeptide or a portion thereof |
| DE69332377T2 (de) * | 1992-07-13 | 2003-07-03 | Bionebraska, Inc. | Verfahren zur modifizierung rekombinanter polypeptide |
| WO1994009116A1 (en) * | 1992-10-15 | 1994-04-28 | Merck & Co., Inc. | Cho cells expressing human endothelin receptors |
| AU6582594A (en) * | 1993-04-26 | 1994-11-21 | Dae Woong Pharmaceutical Co., Ltd. | A novel gene coding human epidermal growth factor and process for preparing the same |
| US5942496A (en) * | 1994-02-18 | 1999-08-24 | The Regent Of The University Of Michigan | Methods and compositions for multiple gene transfer into bone cells |
| US20020193338A1 (en) * | 1994-02-18 | 2002-12-19 | Goldstein Steven A. | In vivo gene transfer methods for wound healing |
| US6551618B2 (en) * | 1994-03-15 | 2003-04-22 | University Of Birmingham | Compositions and methods for delivery of agents for neuronal regeneration and survival |
| US6069230A (en) * | 1994-11-10 | 2000-05-30 | Promega Corporation | High level expression and facile purification of proteins, peptides and conjugates for immunization, purification and detection applications |
| US6764689B1 (en) | 1994-11-10 | 2004-07-20 | Promega Corporation | High level expression and facile purification of proteins, peptides and conjugates for immunization, purification and detection applications |
| AU4415796A (en) * | 1994-12-07 | 1996-06-26 | Bionebraska, Inc. | Production of c-terminal amidated peptides from recombinant protein constructs |
| US6692961B1 (en) * | 1996-10-11 | 2004-02-17 | Invitrogen Corporation | Defined systems for epithelial cell culture and use thereof |
| MX219629B (es) | 1997-04-25 | 2004-03-30 | Sembiosys Genetics Inc | Metodo para separar proteinas de fusion |
| US7531325B2 (en) * | 1997-04-25 | 2009-05-12 | Sembiosys Genetics Inc. | Method for cleavage of fusion proteins |
| KR20020026366A (ko) * | 1999-08-09 | 2002-04-09 | 한스 루돌프 하우스, 헨리에데 부르너 | 단백질의 생산 |
| CA2380302C (en) | 1999-08-09 | 2013-02-26 | Biochemie Gesellschaft M.B.H. | Production of proteins by autoproteolytic cleavage |
| US20060014684A1 (en) * | 2000-03-03 | 2006-01-19 | University Technologies International Inc. | Novel uses of EGF |
| CN100427506C (zh) * | 2001-07-26 | 2008-10-22 | 高级蛋白质技术公司 | 从融合多肽制备感兴趣的多肽的方法 |
| PT1597369E (pt) * | 2003-02-21 | 2008-01-10 | Univ Gent | Processo de produção de polipéptidos fundidos, recombinantes, utilizando as enzimas caspases para amaturação |
| US7084246B2 (en) * | 2003-04-17 | 2006-08-01 | Molecular Logix, Inc. | Epidermal growth factor agonists |
| US20070004036A1 (en) * | 2005-07-01 | 2007-01-04 | Rodolfo Faudoa | Methods and compositions for keratinocyte culture |
| US20070003541A1 (en) * | 2005-07-01 | 2007-01-04 | Rodolfo Faudoa | Methods and compositions for therapeutics |
| AU2007281048B2 (en) * | 2006-08-04 | 2013-07-04 | Adelaide Research And Innovation | Cleavage of BiP by subtilase cytotoxin |
| JP2010524454A (ja) | 2007-04-19 | 2010-07-22 | モレキュラー ディテクション インコーポレーテッド | 抗生物質耐性細菌の検出および分析のための方法、組成物、およびキット |
| US20090192554A1 (en) * | 2008-01-29 | 2009-07-30 | Confluent Surgical, Inc. | Bioabsorbable block copolymer |
| EP2364690A1 (de) * | 2010-02-12 | 2011-09-14 | Centro De Ingenieria Genetica Y Biotecnologia | Oral verabreichbare pharmazeutische Tablette des epidermalen Wachstumsfaktors |
| CN102839205A (zh) * | 2012-08-21 | 2012-12-26 | 任杰 | 一种制造寡肽表皮细胞生长因子干粉的方法 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE38892B1 (en) * | 1973-03-28 | 1978-06-21 | Ici Ltd | Pharmaceutical compositions |
| US4338597A (en) * | 1980-03-06 | 1982-07-06 | Honeywell Information Systems Inc. | Remote monitor interface |
| US4338397A (en) * | 1980-04-11 | 1982-07-06 | President And Fellows Of Harvard College | Mature protein synthesis |
| IE53166B1 (en) * | 1980-08-05 | 1988-08-03 | Searle & Co | Synthetic urogastrone gene,corresponding plasmid recombinants,transformed cells,production thereof and urogastrone expression |
| JPS609795B2 (ja) * | 1980-12-11 | 1985-03-13 | 株式会社林原生物化学研究所 | ヒト上皮細胞成長因子の製造方法 |
| EP0108132A1 (de) * | 1982-05-06 | 1984-05-16 | Applied Molecular Genetics Inc. | Herstellung und expression von genen für urogastron und dessen polypeptidanalogen |
| JPS5882486A (ja) * | 1982-05-17 | 1983-05-18 | 松下電工株式会社 | 平板型整流子の製造方法 |
| IL71991A (en) * | 1983-06-06 | 1994-05-30 | Genentech Inc | Preparation of human FGI and FGE in their processed form through recombinant AND tranology in prokaryotes |
| JPS60501737A (ja) * | 1983-07-05 | 1985-10-17 | チロン コ−ポレイシヨン | 上皮成長因子のハイブリドｄｎａ合成 |
| JPS6028994A (ja) * | 1983-07-08 | 1985-02-14 | Wakunaga Seiyaku Kk | 〔２１―ロイシン〕ヒトウロガストロン |
| US4710473A (en) * | 1983-08-10 | 1987-12-01 | Amgen, Inc. | DNA plasmids |
| IL69719A0 (en) * | 1983-09-14 | 1983-12-30 | Yeda Res & Dev | Synthetic peptides with egf like activity |
| WO1985002198A1 (en) * | 1983-11-01 | 1985-05-23 | Amgen | Microbial expression of type i transforming growth factor, polypeptide analogs thereof and hybrid egf/tgf polypeptides |
| JPS60130393A (ja) * | 1983-12-19 | 1985-07-11 | Sumitomo Chem Co Ltd | ヒトウロガストロン遺伝子，対応する組換えプラズミド及び組換え体 |
| JPS60130397A (ja) * | 1983-12-19 | 1985-07-11 | Sumitomo Chem Co Ltd | ヒトウロガストロンの微生物学的製造法 |
| EP0147178B1 (de) * | 1983-12-23 | 1991-08-14 | Pfizer Inc. | Expressionsplasmide für die Herstellung eines heterologen Proteins in Bakterien |
| JP2554459B2 (ja) * | 1984-07-02 | 1996-11-13 | アース製薬 株式会社 | β−ウロガストロン遺伝子、対応プラスミド組換体及び対応形質転換体 |
| JPS61185197A (ja) * | 1984-08-17 | 1986-08-18 | Sumitomo Chem Co Ltd | ウロガストロンの微生物学的製造法 |
| CA1263619A (en) * | 1984-10-09 | 1989-12-05 | Ryuji Marumoto | Dna, production and use thereof |
| EP0200757B1 (de) * | 1984-10-19 | 1992-03-11 | Chiron Corporation | Anregung zur heilung einer wunde mittels menschlichen hautwachstumsfaktors hergestellt durch rekombinant-dns |
| JP2549504B2 (ja) * | 1984-12-21 | 1996-10-30 | ア−ス製薬株式会社 | Ｄｎａ塩基配列、ポリペプチド分泌発現ベクター及び形質転換微生物 |
| JPS61167625A (ja) * | 1985-01-22 | 1986-07-29 | Wakunaga Seiyaku Kk | 消化管粘膜保護剤 |
| GB8507666D0 (en) * | 1985-03-25 | 1985-05-01 | Wellcome Found | Epidermal growth factor production |
| EP0207044A1 (de) * | 1985-06-20 | 1986-12-30 | Monsanto Company | Freisetzung von Peptiden aus Polypeptiden |
-
1986
- 1986-02-24 US US06/832,337 patent/US4743679A/en not_active Expired - Lifetime
-
1987
- 1987-02-05 CA CA000529101A patent/CA1269055A/en not_active Expired - Lifetime
- 1987-02-18 AU AU69011/87A patent/AU595290B2/en not_active Ceased
- 1987-02-20 EP EP87301490A patent/EP0234888B1/de not_active Expired - Lifetime
- 1987-02-20 DE DE87301490T patent/DE3785864T2/de not_active Expired - Fee Related
- 1987-02-20 AT AT87301490T patent/ATE89602T1/de not_active IP Right Cessation
- 1987-02-24 JP JP62041229A patent/JPS62246600A/ja active Pending
-
1988
- 1988-01-04 US US07/140,739 patent/US5004686A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU6901187A (en) | 1987-08-27 |
| US4743679A (en) | 1988-05-10 |
| US5004686A (en) | 1991-04-02 |
| EP0234888B1 (de) | 1993-05-19 |
| AU595290B2 (en) | 1990-03-29 |
| DE3785864T2 (de) | 1994-01-20 |
| DE3785864D1 (de) | 1993-06-24 |
| EP0234888A3 (en) | 1988-09-14 |
| EP0234888A2 (de) | 1987-09-02 |
| CA1269055A (en) | 1990-05-15 |
| JPS62246600A (ja) | 1987-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3785864D1 (de) | Verfahren zur herstellung von menschlichem epidermalwachstumsfaktor und dessen analogen. | |
| ATE124997T1 (de) | Enzymatische entfernung einer aminoterminalen proteinsequenz. | |
| DE69201959D1 (de) | Verfahren zur Herstellung von 6,12-Dihydro-6-hydroxy-cannabidiol und dessen Anwendung zur Herstellung von trans-delta-9-Tetrahydrocannabinol. | |
| ATE102617T1 (de) | Verfahren zur herstellung von zyklischen estern hoher reinheit. | |
| ATE68826T1 (de) | Verfahren zur herstellung von reifem, menschlichem serum-albumin. | |
| CA2019363A1 (en) | Dna and use thereof | |
| DE69126646D1 (de) | Biologisches Verfahren zur Herstellung von optisch-aktiver Milchsäure | |
| ATE23578T1 (de) | Verfahren zur herstellung von (omegafluorsulfonyl)-haloaliphatischen carbonsaeurefluoriden. | |
| DE69011880D1 (de) | Verfahren zur Herstellung von L-Aminosäuren durch Fermentation. | |
| DE3683512D1 (de) | Verfahren zur optischen isomerisierung von optisch aktiver aminosaeure und verfahren zur herstellung von optisch aktiver aminosaeure. | |
| DE3871410D1 (de) | (phenylethenyl)phenylpropionaldehyd und verfahren zur herstellung von (benzoylphenyl)propionsaeure unter verwendung dieser verbindung. | |
| ATE116636T1 (de) | Verfahren zur herstellung von 2,6- dichlordiphenylaminessigsäurederivaten. | |
| DE68926417D1 (de) | Verfahren zur herstellung von optisch aktiven 2-hydroxysäureabkömmlingen | |
| DE58903876D1 (de) | Riboflavin-4'5'-cyclo-phosphorsaeureesterchlorid, dessen herstellung und verwendung zur herstellung von riboflavin-5'-phosphat (5'-fmn) bzw. dessen natriumsalz. | |
| DE68926922D1 (de) | Verfahren zur Herstellung von L-alpha-Aminosäuren | |
| DE69033833D1 (de) | Verfahren zur Herstellung von Butantetracarbonsäure | |
| ES2125216T3 (es) | Procedimiento para la produccion de polipeptidos recombinantes con actividad de hormona porcina del crecimiento. | |
| ATE74353T1 (de) | Verfahren zur herstellung von n,n(dibenzohexatrienylen)harnstoffen. | |
| PT82536A (de) | Verfahren zur herstellung von 17alpha-ethinyl-17 beta-hydroxy-18-methyl-4,15-estradien-3-on und die neuen ausgangsverbindungenfur dieses verfahren | |
| DE3884324D1 (de) | Verfahren zur Herstellung von menschlichen pro-apolipoprotein-A-I-ähnlichen Proteinen. | |
| ATE69804T1 (de) | Verfahren zur herstellung von d- oder l-alanin hoher enantiomerenreinheit. | |
| DE58907892D1 (de) | Verfahren zur Herstellung von optisch aktiven alpha-Aminoacetalen. | |
| ATE81013T1 (de) | Verfahren zur herstellung von faktor viii:cmangelplasma und ein so erhaltenes mangelplasma. | |
| ATE95187T1 (de) | Verfahren zur gewinnung, isolierung und reinigung von epidermin. | |
| DE3851942D1 (de) | Verfahren zur Herstellung von optisch aktiver alpha-Isopropyl-p-chlorophenylessigsäure. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |